镓标记PSMA PET在根治性前列腺切除术后生化复发患者中的淋巴结检出性能
结果显示,按患者计算阳性预测值为82%,按病灶计算敏感度仅36.7%、特异度96.9%,提示该影像在挽救性治疗场景下敏感度不足,可能漏诊广泛转移。
要点
- 按患者计算,镓标记PSMA PET的阳性预测值为82%。
- 按病灶计算,敏感度36.7%、特异度96.9%、阳性预测值73.5%、阴性预测值86.7%。
- 影像敏感度不足,可能漏诊影像阴性的广泛转移病灶。
核心结论
- 镓标记PSMA PET在挽救性治疗场景下的敏感度尚不足以检出所有转移部位,影像引导的转移灶靶向治疗可能因合并影像阴性的更广泛病灶而失败。
主要发现
- 镓标记PSMA PET共检出34个阳性淋巴结,每例中位数2个(IQR 1-3个)。
- 按患者计算阳性预测值为82%。
- 因所有患者均有可检测PSA的疾病复发,无法计算敏感度、特异度和阴性预测值。
- 按病灶计算,敏感度36.7%、特异度96.9%、阳性预测值73.5%、阴性预测值86.7%。
临床怎么用
- 在挽救性淋巴结清扫决策中,应认识到镓标记PSMA PET可能漏诊病灶,影像引导的靶向治疗需谨慎评估。
局限性
- 所有患者均有生化复发,无法计算按患者的敏感度、特异度和阴性预测值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To assess the performance of Ga-labeled prostate-specific membrane antigen ligand-positron-emission tomography (Ga-PSMA PET) for positive lymph nodes on imaging after curatively intended radical prostatectomy. PATIENTS AND METHODS: Seventeen patients with biochemical recurrence after radical prostatectomy undergoing robot-assisted salvage lymphadenectomy for positive lymph nodes on imaging were included in this single surgeon study. The performance of Ga-PSMA PET was assessed on per patient, per lesion, per landing site and per laterality level using sensitivity, specificity, and negative and positive predictive value analysis. RESULTS: A total of 34 positive nodes were detected on Ga-PSMA PET with a median of 2 nodes per patient (IQR 1-3 nodes per patient). Sixty six nodes were pathologically disease positive from 14 patients, with a median of 2 positive nodes per patient (IQR 1-6). Three patients had no pathologically detectable disease. On a per patient basis, the positive predictive value was 82%. Sensitivity, specificity, and negative predictive value were not able to be calculated as all patients had disease recurrence with a detectable prostate-specific antigen.On a "per lesion" basis, the sensitivity, specificity, positive predictive value, and negative predictive value were 36.7%, 96.9%, 73.5%, and 86.7%, respectively. CONCLUSION: Our study indicates that sensitivity of Ga-PSMA PET in the salvage setting is not yet sufficient to detect all sites of metastasis. Therefore, imaging-guided metastasis targeted treatment is likely to fail given the likely concomitant imaging negative more widespread disease.
引用
- Dundee P, Gross T, Moran D, et al. Ga-labeled Prostate-specific Membrane Antigen Ligand-positron-emission Tomography: Still Just the Tip of the Iceberg. Urology. 2018. PMID: 29964126. doi:10.1016/j.urology.2018.06.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。